Woodline Partners’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100,000
| Closed | -$1.17M | – | 689 |
|
|
2024
Q2 | $1.17M | Sell |
100,000
-46,334
| -32% | -$542K | 0.01% | 447 |
|
|
2024
Q1 | $3.08M | Buy |
+146,334
| New | +$3.08M | 0.03% | 402 |
|
|
2023
Q2 | – | Sell |
-305,822
| Closed | -$5.78M | – | 729 |
|
|
2023
Q1 | $5.78M | Sell |
305,822
-214,813
| -41% | -$4.06M | 0.08% | 270 |
|
|
2022
Q4 | $11.8M | Buy |
+520,635
| New | +$11.8M | 0.16% | 179 |
|
|
2021
Q1 | – | Sell |
-48,329
| Closed | -$2.19M | – | 469 |
|
|
2020
Q4 | $2.19M | Sell |
48,329
-227,113
| -82% | -$10.3M | 0.06% | 193 |
|
|
2020
Q3 | $7.58M | Buy |
275,442
+133,731
| +94% | +$3.68M | 0.25% | 102 |
|
|
2020
Q2 | $5.22M | Sell |
141,711
-12,910
| -8% | -$475K | 0.21% | 110 |
|
|
2020
Q1 | $5.01M | Buy |
+154,621
| New | +$5.01M | 0.36% | 87 |
|